Chilean AstraZeneca trial saw no cases of blood clots — trial leaders

  • 📰 inquirerdotnet
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 86%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Chilean investigators testing the AstraZeneca-Oxford University COVID-19 vaccination in 2,200 people found no instances of blood clots among participants, they said.

On Friday, Chile took delivery of the first 158,400 of a promised 800,000 doses delivered through the COVAX vaccines alliance.

Vaxzevria was approved for emergency use in Chile in January for men over 18 and women over 55 but will be used only for men since most women over 55 in Chile have already been vaccinated, the health minister said. “All the trials show that the risks are minimal compared to the protection factor a vaccine carries,” he said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Hi . I am 44 years male . I got first dose of AZ jab 6 weeks earlier. I am healthy. Is there any chance of blood clotting after 2nd dose . I have little hesitation to get 2nd dose . At my first dose there is no blood clotting cases in Europe and Canada. Please help me out

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in LAW

Law Law Latest News, Law Law Headlines